RNA Pioneering SA
RNA Pioneering reported total assets of €5.63m at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
By total assets for 2025, RNA Pioneering ranks among the 5,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of RNA Pioneering shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +378 % Total assets +384 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
RNA Pioneering's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −128,247 € | ||||
| Equity | €5.51m | ||||
| Cash | 198,540 € | ||||
| EBITDA | −114,428 € | ||||
| Total assets | €5.63m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 28 Sep 2023
- Year ended 31 Dec 2021filed on 09 Sep 2022
RNA Pioneering's financial analysis
- Solvency97.9%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of RNA Pioneering
RNA Pioneering's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0456.792.695
- VAT number
- BE0456792695
- Peppol
- Registered · 0208:0456792695 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Dec 1995
- Registered office
- 9052 Ghent
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
RNA Pioneering (SA) has been based in Ghent since 1995, active in: business and other management consultancy activities. For 2025, it reports a net loss of 128,247 € and equity of €5.51m; its revenue is not published. Its solvency stands at 97.9%, above the median of its sector (58.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to RNA Pioneering
Companies in the same business, of comparable size and area, outside its group.
- Contipharma Wholesale of pharmaceutical and medical goods Seraing · balance sheet €7.21m
- GUANG JI Pharmaceutical Belgium sa Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 32,994 €
- Curium Belgium Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €5.44m
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Hemotech Belux Wholesale of pharmaceutical and medical goods Koekelare · balance sheet €4.96m
- Chaflo Retail sale of pharmaceutical products Dendermonde · balance sheet €6.17m
- KYKS Business and other management consultancy activities Forest · balance sheet €2.70m
- Van Haren Management Business and other management consultancy activities Sprimont · balance sheet €2.60m
Frequently asked questions about RNA Pioneering
What is the revenue of RNA Pioneering?
RNA Pioneering files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of RNA Pioneering?
In Belgium, the VAT number is the company number prefixed with BE: BE0456792695 for RNA Pioneering, if the company is VAT-registered. Its company number (CBE) is 0456.792.695.
Where is the registered office of RNA Pioneering?
According to the CBE register, the registered office of RNA Pioneering is in 9052 Ghent.
What is the equity of RNA Pioneering?
At the close of the 2025 financial year, the equity of RNA Pioneering amounts to 5,508,642 €, a solvency of 97.9% of total assets.
Who manages RNA Pioneering?
The register lists 5 active mandates at RNA Pioneering. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is RNA Pioneering within its sector?
By total assets for 2025, RNA Pioneering ranks among the 5,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of RNA Pioneering
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →